Larry Grace

Larry Grace currently serves as Chief Business Officer at Prellis Biologics, having previously held the position of Senior Director of Portfolio Management at Generate Biomedicines, Inc. Larry's extensive experience includes an Executive Director role in Innovation & Strategic Partnerships at Amgen, where responsibilities encompassed leading strategic development and partnerships to enhance R&D capabilities. Prior roles at Amgen also involved directing corporate strategy initiatives and optimizing business performance, achieving significant operational savings and strategic advancements. Larry's background includes positions at Novartis in Asia Operations for Molecular Diagnostics and roles in investment analysis and legal restructuring. Educationally, Larry holds a Juris Doctor and an MBA from Northwestern University, as well as Master's and Bachelor's degrees in Biophysics and Nuclear Engineering from the University of California, Berkeley.